Medicine
Aralast NP kit
Aralast NP kit is a prescription medicine containing Alpha-1-proteinase inhibitor, marketed by Takeda Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store ARALAST NP at temperatures not to exceed 25°C (77°F)…
Key facts
- Active ingredient (INN)
- Alpha-1-proteinase inhibitor
- Brand
- Aralast NP
- Dosage form
- Kit
- Packs
- 1 kit
- Marketing authorisation holder
- Takeda Pharmaceuticals
- Manufacturer
- Takeda Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store ARALAST NP at temperatures not to exceed 25°C (77°F). Store ARALAST NP in the original carton to protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3002.12Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 December 2002
- Identifiers
- RxCUI 1233711, 1661208DailyMed set ID a9a5b46e-04da-41bd-bb5f-c4936b664fefNDC 0944-2815, 0944-2814Application BLA125039
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 kit in 1 carton * 25 mL in 1 vial, glass * 25 mL in 1 vial | 0944-2814-01 | Takeda Pharmaceuticals | 23 December 2002 |
| 1 kit in 1 carton * 50 mL in 1 vial * 50 mL in 1 vial, glass | 0944-2815-01 | Takeda Pharmaceuticals | 23 December 2002 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Alpha-1-proteinase inhibitor kit.
Clinical summary
Alpha-1-proteinase inhibitor is a prescription medicine indicated for chronic augmentation therapy in adults with clinically evident emphysema due to severe congenital deficiency of Alpha 1 -PI (alpha 1 -antitrypsin deficiency), among other approved uses. MedsAcross supplies Alpha-1-proteinase inhibitor for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Alpha-1-proteinase inhibitorFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Aralast NP prescribing information (Takeda Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Aralast NP kit for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.